86 related articles for article (PubMed ID: 22517832)
1. Biomedicine. Nanoparticle treatment reverses cerebral palsy in rabbits.
Miller G
Science; 2012 Apr; 336(6079):286. PubMed ID: 22517832
[No Abstract] [Full Text] [Related]
2. Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.
Nemeth CL; Drummond GT; Mishra MK; Zhang F; Carr P; Garcia MS; Doman S; Fatemi A; Johnston MV; Kannan RM; Kannan S; Wilson MA
Nanomedicine; 2017 Oct; 13(7):2359-2369. PubMed ID: 28669854
[TBL] [Abstract][Full Text] [Related]
3. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
[TBL] [Abstract][Full Text] [Related]
4. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Kannan S; Dai H; Navath RS; Balakrishnan B; Jyoti A; Janisse J; Romero R; Kannan RM
Sci Transl Med; 2012 Apr; 4(130):130ra46. PubMed ID: 22517883
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.
Dai H; Navath RS; Balakrishnan B; Guru BR; Mishra MK; Romero R; Kannan RM; Kannan S
Nanomedicine (Lond); 2010 Nov; 5(9):1317-29. PubMed ID: 21128716
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
Zawadzka M; Kaminska B
Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Paintlia MK; Paintlia AS; Barbosa E; Singh I; Singh AK
J Neurosci Res; 2004 Nov; 78(3):347-61. PubMed ID: 15389835
[TBL] [Abstract][Full Text] [Related]
8. Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury.
Pang Y; Rodts-Palenik S; Cai Z; Bennett WA; Rhodes PG
Brain Res Dev Brain Res; 2005 Jun; 157(2):141-9. PubMed ID: 15878785
[TBL] [Abstract][Full Text] [Related]
9. Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats.
Chu LS; Fang SH; Zhou Y; Yin YJ; Chen WY; Li JH; Sun J; Wang ML; Zhang WP; Wei EQ
Life Sci; 2010 Jan; 86(5-6):170-7. PubMed ID: 20006627
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine in cerebral palsy.
Balakrishnan B; Nance E; Johnston MV; Kannan R; Kannan S
Int J Nanomedicine; 2013; 8():4183-95. PubMed ID: 24204146
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
12. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone.
Barreto G; Veiga S; Azcoitia I; Garcia-Segura LM; Garcia-Ovejero D
Eur J Neurosci; 2007 May; 25(10):3039-46. PubMed ID: 17561817
[TBL] [Abstract][Full Text] [Related]
13. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
Nance E; Zhang F; Mishra MK; Zhang Z; Kambhampati SP; Kannan RM; Kannan S
Biomaterials; 2016 Sep; 101():96-107. PubMed ID: 27267631
[TBL] [Abstract][Full Text] [Related]
14. Evidence for therapeutic intervention in the prevention of cerebral palsy: hope from animal model research.
Nguyen A; Armstrong EA; Yager JY
Semin Pediatr Neurol; 2013 Jun; 20(2):75-83. PubMed ID: 23948682
[TBL] [Abstract][Full Text] [Related]
15. Microglia and cyclooxygenase-2: possible therapeutic targets of progesterone for stroke.
Jiang C; Cui K; Wang J; He Y
Int Immunopharmacol; 2011 Nov; 11(11):1925-31. PubMed ID: 21843661
[TBL] [Abstract][Full Text] [Related]
16. Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy.
Sah N; Zhang Z; Chime A; Fowler A; Mendez-Trendler A; Sharma A; Kannan RM; Slusher B; Kannan S
Dev Neurosci; 2023; 45(5):268-275. PubMed ID: 36990069
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective strategies for the neonatal brain.
Degos V; Loron G; Mantz J; Gressens P
Anesth Analg; 2008 Jun; 106(6):1670-80. PubMed ID: 18499596
[TBL] [Abstract][Full Text] [Related]
18. [Excitotoxic cascade and neuroprotection in various stages of cerebral development].
Evrard P; Marret S; Gressens P
Bull Mem Acad R Med Belg; 1997; 152(3):159-65; discussion 165-7. PubMed ID: 9491637
[TBL] [Abstract][Full Text] [Related]
19. Novel 2-alkylamino-1,4-benzoxazine derivatives as potent neuroprotective agents: structure-activity relationship studies.
Blattes E; Lockhart B; Lestage P; Schwendimann L; Gressens P; Fleury MB; Largeron M
J Med Chem; 2005 Feb; 48(4):1282-6. PubMed ID: 15715499
[TBL] [Abstract][Full Text] [Related]
20. Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.
Zhang F; Nance E; Zhang Z; Jasty V; Kambhampati SP; Mishra MK; Burd I; Romero R; Kannan S; Kannan RM
J Control Release; 2016 Sep; 237():61-70. PubMed ID: 27378700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
